contexttherapeutics.com
Identification of CTX-30916 as a new antagonist of progesterone receptor signaling pathways — Context Therapeutics
Deepak Lala and Tasir Haque AACR 2019 Annual Meeting I Abstract 2625 I March 31 - April 3, 2019